H.B. Fuller (NYSE:FUL – Get Rating) updated its FY 2022 earnings guidance on Wednesday. The company provided earnings per share guidance of $4.13-$4.27 for the period, compared to the consensus earnings per share estimate of $4.23. The company issued revenue guidance of -. H.B. Fuller also updated its Q4 2022 guidance to $1.15-$1.30 EPS.
Analyst Upgrades and Downgrades
A number of research firms have weighed in on FUL. Deutsche Bank Aktiengesellschaft decreased their price objective on H.B. Fuller from $85.00 to $72.00 and set a buy rating on the stock in a report on Friday, June 24th. JPMorgan Chase & Co. downgraded H.B. Fuller from a neutral rating to an underweight rating and decreased their price objective for the company from $70.00 to $52.00 in a report on Friday, June 24th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and three have issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of Hold and a consensus price target of $71.00.
Get
H.B. Fuller alerts:
H.B. Fuller Price Performance
Shares of NYSE:FUL traded up $1.19 during trading on Friday, reaching $61.66. The stock had a trading volume of 6,693 shares, compared to its average volume of 305,946. H.B. Fuller has a 52 week low of $57.36 and a 52 week high of $81.73. The business's 50-day moving average price is $64.81 and its 200 day moving average price is $65.54. The company has a debt-to-equity ratio of 1.19, a current ratio of 1.93 and a quick ratio of 1.18. The stock has a market capitalization of $3.29 billion, a PE ratio of 16.94 and a beta of 1.54.
H.B. Fuller (NYSE:FUL – Get Rating) last posted its earnings results on Wednesday, September 21st. The specialty chemicals company reported $1.06 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.05 by $0.01. H.B. Fuller had a net
margin of 5.33% and a return on equity of 13.89%. The company had revenue of $941.20 million during the quarter, compared to analysts' expectations of $944.11 million. During the same quarter in the previous year, the company posted $0.79 earnings per share. H.B. Fuller's quarterly revenue was up 13.8% compared to the same quarter last year. As a group, equities analysts predict that H.B. Fuller will post 4.2 earnings per share for the current year.
Insider Buying and Selling
In other H.B. Fuller news, VP Nathan D. Weaver sold 5,988 shares of the company's stock in a transaction on Monday, July 25th. The shares were sold at an average price of $62.82, for a total transaction of $376,166.16. Following the completion of the sale, the vice president now owns 3,766 shares in the company, valued at approximately $236,580.12. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, VP Nathan D. Weaver sold 5,988 shares of the company's stock in a transaction on Monday, July 25th. The shares were sold at an average price of $62.82, for a total value of $376,166.16. Following the completion of the transaction, the vice president now directly owns 3,766 shares of the company's stock, valued at approximately $236,580.12. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Trangsrud Teresa J. Rasmussen bought 1,000 shares of H.B. Fuller stock in a transaction that occurred on Tuesday, July 5th. The stock was bought at an average cost of $58.20 per share, with a total value of $58,200.00. Following the completion of the purchase, the director now owns 1,000 shares in the company, valued at approximately $58,200. The disclosure for this purchase can be found here. 4.69% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On H.B. Fuller
Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Eagle Bay Advisors LLC bought a new stake in shares of H.B. Fuller in the 2nd quarter valued at about $33,000. MetLife Investment Management LLC raised its holdings in shares of H.B. Fuller by 55.7% in the 1st quarter. MetLife Investment Management LLC now owns 27,833 shares of the specialty chemicals company's stock valued at $1,839,000 after purchasing an additional 9,960 shares during the period. Luminus Management LLC bought a new stake in shares of H.B. Fuller in the 1st quarter valued at about $3,396,000. Finally, UBS Asset Management Americas Inc. raised its holdings in shares of H.B. Fuller by 4.9% in the 2nd quarter. UBS Asset Management Americas Inc. now owns 66,538 shares of the specialty chemicals company's stock valued at $4,006,000 after purchasing an additional 3,081 shares during the period. 96.38% of the stock is owned by institutional investors.
About H.B. Fuller
(Get Rating)
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products worldwide. The company operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.
See Also
- Get a free copy of the StockNews.com research report on H.B. Fuller (FUL)
- This Is A Memorable Time To Buy Into Micron Technology
- Declining Profits Challenge the CarMax Value Proposition
- Thor Industries Hammers Out A Bottom
- How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
- Let Paychex Stock Work Hard For You
Receive News & Ratings for H.B. Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H.B. Fuller and related companies with MarketBeat.com's FREE daily email newsletter.
